Advisor Group Holdings, Inc. Abcam PLC Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.54 - $24.41 $71,598 - $81,138	3,324 Added 21.4%	18,854 $426,000
Q2 2023 Aug 10, 2023	BUY	$12.62 - $24.47 $79,972 - $155,066	6,337 Added 68.93%	15,530 $380,000
Q1 2023 May 12, 2023	BUY	$12.98 - $17.1 $3,945 - $5,198	304 Added 3.42%	9,193 $123,000
Q4 2022 Feb 10, 2023	BUY	$13.92 - $17.0 $38,725 - $47,294	2,782 Added 45.55%	8,889 $138,000
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $6,680 - $8,375	500 Added 8.92%	6,107 $92,000
Q2 2022 Aug 10, 2022	SELL	$12.69 - $19.25 $3,464 - $5,255	-273 Reduced 4.64%	5,607 $81,000
Q1 2022 May 04, 2022	BUY	$15.5 - $23.89 $15,546 - $23,961	1,003 Added 20.57%	5,880 $108,000
Q3 2021 Nov 05, 2021	SELL	$17.38 - $21.54 $3,093 - $3,834	-178 Reduced 3.52%	4,877 $99,000
Q2 2021 Aug 02, 2021	BUY	$18.47 - $22.11 $8,773 - $10,502	475 Added 10.37%	5,055 $96,000
Q1 2021 May 13, 2021	BUY	$19.22 - $24.3 $28,368 - $35,866	1,476 Added 47.55%	4,580 $88,000
Q4 2020 Feb 10, 2021	BUY	$18.2 - $22.45 $56,492 - $69,684	3,104 New	3,104 $67,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.